To prepare for emerging mRNA technologies, it is necessary to adapt fill/finish and cold chain capabilities.
Jeong Jin-hyeok
Advertisement
Jeong Jin-hyeok is principal scientist in drug product at Samsung Biologics.
Articles by Jeong Jin-hyeok
Advertisement
Latest Updated Articles
Preparing for a New Wave of mRNA TechnologiesPublished: May 15th 2023 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
2
Establishing Risk Assessments for AI in Bio-Manufacturing
3
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
4
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
5
